zinc sulfate has been researched along with Clerambault Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sinha, S; Taly, AB | 1 |
| Dieu, C; Hartard, C; Kunze, K; Weisner, B | 1 |
2 other study(ies) available for zinc sulfate and Clerambault Syndrome
| Article | Year |
|---|---|
Withdrawal of penicillamine from zinc sulphate-penicillamine maintenance therapy in Wilson's disease: promising, safe and cheap.
Topics: Adolescent; Adult; Astringents; Chelating Agents; Chelation Therapy; Child; Child, Preschool; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Neurocognitive Disorders; Penicillamine; Retrospective Studies; Treatment Outcome; Zinc Sulfate | 2008 |
Wilson's disease with cerebral manifestation: monitoring therapy by CSF copper concentration.
Topics: Adult; Brain; Ceruloplasmin; Chelation Therapy; Copper; Female; Hepatolenticular Degeneration; Humans; Male; Neurocognitive Disorders; Penicillamine; Sulfates; Zinc Compounds; Zinc Sulfate | 1993 |